Cannabis brands cannot advertise on Google. Cannot run Facebook or Instagram campaigns. Cannot appear on YouTube as paid promotion. Cannot buy national television or radio time. The primary paid media channels that every other consumer brand uses to build awareness are categorically unavailable to cannabis operators, regardless of state legalization status.
This is not a new observation. What is new is the data on what that constraint actually costs brands that don’t respond to it correctly — and what it produces for the ones that do.
5W today published The Cannabis Communications Gap, a 2026 research report that documents the structural mismatch across the cannabis communications landscape and provides the most detailed celebrity brand performance analysis published to date. The full report is free at 5wpr.com/research/cannabis-communications-gap. For PR practitioners, it is required reading for anyone working in or adjacent to the cannabis category.
The Gap in Numbers
Cannabis brands spend 80% less on marketing than CPG competitors as a percentage of revenue, and 75% less than traditional retail. The Revenue-to-ad-spend gap is widening. Within the already-undersized marketing budget, allocation patterns tilt toward restricted channels (social media, programmatic) and away from thechannels where cannabis has no restrictions at all — earned media, SEO, owned content, and compliant influencer strategy. The brands that have figured out the unrestricted channels are pulling away from the ones that haven’t.
The Rescheduling Opportunity for Communicators
President Trump’s December 2025 executive order directing the DOJ to complete cannabis rescheduling to Schedule III is the most significant regulatory development in the industry’s history. The final rule, expected in the first half of 2026, eliminates Section 280E — meaning marketing expenses become federally deductible for cannabis operators for the first time. The after-tax economics of communications investment improve immediately upon the rule taking effect.
For PR practitioners, the rescheduling process itself is a major earned media opportunity. The operators thathave existing relationships with the reporters covering this story will shape the coverage. Those that don’t will be described by their competitors and by critics. The communications firms and in-house teams that positioned cannabis clients before the rescheduling news cycle will demonstrate the clearest possible ROI for proactive media relations investment.
The Celebrity Performance Data Is a Case Study in Why Authenticity Wins
Hoodie Analytics’ 2024 sales data shows Khalifa Kush at $50 million in annual sales and Snoop Dogg’s Death Row Cannabis at $2–3 million, ranked 20th among celebrity cannabis brands. Two of the most famous cannabis advocates in American culture, $47 million apart in brand sales. The gap is explained entirely by authenticity of brand structure and consistency of communications strategy, not by awareness.
Khalifa Kush was built over a decade before it became a commercial product. Snoop Dogg’s legacy Leafs By Snoop brand, licensed through Canopy Growth, underperformed by Canopy’s own admission. His Death Row Cannabis brand is a newer owned vehicle without that accumulated equity. The lesson for any communications practitioner advising on celebrity partnerships: famous names produce launch coverage, not sustained brand equity. The sustained equity comes from authentic connection and consistent communications strategy over time.
The FTC Environment Is More Consequential Than Most Cannabis Brands Realize
The FTC’s updated Endorsement Guides, effective October 2024, impose brand-level liability for influencer content including posts the brand never reviewed. At $53,088 per violation in 2025, a non-compliant influencer campaign is a material financial exposure. Four of five influencers still fail to properly disclose paid partnerships, per industry data. Cannabis brands are operating in a channel environment where influencer marketing is one of the most important available options — and where the legal exposure from running it wrong has never been higher.
The report provides the five-element compliance infrastructure. It is not complex. It is simply not being built by most cannabis marketing teams before they launch influencer programs.
The MSO Earned Media Problem
The largest cannabis companies in the United States — Curaleaf, Green Thumb Industries, Trulieve, Verano — generate $1 billion or more in annual revenue and are publicly traded. They generate fewer than 10 Tier 1 mediamentions per quarter. Comparable CPG companies at the same revenue level generate 40 to 80. Comparable biotech companies generate 80 to 150. The MSO earned media gap is not a communications preference. It is astructural liability heading into the rescheduling period, when institutional capital will evaluate this category for the first time and the companies with established investor relations and media profiles will access capital at lower cost than those without.
The Cannabis Communications Gap 2026 report is free at 5wpr.com/research/cannabis-communications-gap.
